Atlas Trials

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

Clinical trial NCT01444547 · UNKNOWN

Trial details

NCT number
NCT01444547
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2007-01-01
Primary completion
2015-12-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.